Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Somatic cell nuclear transfer.

Ian Wilmut1, Lesley Paterson

  • 1Roslin Institute, Roslin, Midlothian, EH25 9PS, UK. ian.wilmut@bbsrc.ac.uk

Oncology Research
|May 3, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Endothelial Progenitor Cells Do Not Originate From the Bone Marrow.

Circulation·2019
Same author

Cloning After Dolly.

Cellular reprogramming·2018
Same author

C9ORF72 repeat expansion causes vulnerability of motor neurons to Ca<sup>2+</sup>-permeable AMPA receptor-mediated excitotoxicity.

Nature communications·2018
Same author

Towards the isolation of embryonal stem cell lines from the sheep.

Roux's archives of developmental biology : the official organ of the EDBO·2017
Same author

Development of an inducible platform for intercellular protein delivery.

International journal of pharmaceutics·2017
Same author

Chondrocytes Derived From Mesenchymal Stromal Cells and Induced Pluripotent Cells of Patients With Familial Osteochondritis Dissecans Exhibit an Endoplasmic Reticulum Stress Response and Defective Matrix Assembly.

Stem cells translational medicine·2016
Same journal

New Paradigm in Ocular Surface Squamous Neoplasia-Insights from a Case Report on the Use of Interferon in Treatment.

Oncology research·2026
Same journal

Clinical Application Progress of Artificial Intelligence in Pancreatic Cancer: From Diagnosis to Immunotherapy.

Oncology research·2026
Same journal

Exploring the Role of CD44 in the Progression and Invasion of Chondrosarcoma.

Oncology research·2026
Same journal

Retraction: Long Noncoding RNA Taurine-Upregulated Gene 1 Promotes Cell Proliferation and Invasion in Gastric Cancer via Negatively Modulating miRNA-145-5p.

Oncology research·2026
Same journal

Retraction: Knockdown of Cyclin-Dependent Kinase Inhibitor 3 Inhibits Proliferation and Invasion in Human Gastric Cancer Cells.

Oncology research·2026
Same journal

Targeting Dynamin-Related Protein 1 and Glucose Metabolism Reverses Acquired Resistance to Sorafenib in Liver Cancer.

Oncology research·2026
See all related articles

Somatic cell nuclear transfer can generate patient-specific embryonic stem cells for treating degenerative diseases. However, current low efficiency and high costs limit widespread clinical application.

Area of Science:

  • Biotechnology
  • Regenerative Medicine
  • Developmental Biology

Background:

  • Embryonic stem cells (ESCs) derived from somatic cell nuclear transfer (SCNT) offer potential for treating human degenerative diseases.
  • SCNT-derived ESCs are histocompatible, possess normal lifespan potential, and can differentiate into various cell types.

Purpose of the Study:

  • To evaluate the potential of SCNT-derived ESCs for therapeutic applications.
  • To identify limitations and areas for improvement in SCNT technology for clinical use.

Main Methods:

  • Nuclear transfer from patient somatic cells into enucleated oocytes.
  • Developmental assessment of reconstructed embryos.
  • Analysis of gene expression and chromatin structure in early embryos.

Related Experiment Videos

Main Results:

  • SCNT has been successful in five species, but efficiency remains low (1-4% of embryos develop to adulthood).
  • In vitro development is repeatable, but in vivo development is inefficient due to multi-stage failures.
  • Gene expression and chromatin structure abnormalities are implicated in developmental failures.

Conclusions:

  • SCNT-derived ESCs hold promise for regenerative medicine but face significant efficiency challenges.
  • Improving SCNT efficiency requires a deeper understanding of early embryonic gene regulation and chromatin dynamics.
  • Further research into developmental mechanisms is crucial for the clinical translation of SCNT technology.